Twenty‐Four Month Outcomes From a Real‐World Telehealth Obesity Treatment Clinic Using Obesity Medications
Authors' conclusion
This real-world analysis found 18- and 24-month weight losses comparable to those demonstrated in clinical trials, supporting the long-term efficacy of AOMs provided by a telemedicine weight management clinic. Continued weight loss was demonstrated between 18 and 24 months, suggesting sustained engagement with AOMs and a telemedicine weight management clinic support continued weight loss in the long term.
Study context
- Population
- Adults using antiobesity medications (AOMs) at a telemedicine weight management clinic, January 2022–December 2024
- Participants
- 11,675 vs 4,317
- Exposure
- ≥ 18 months vs ≥ 24 months
- ≥ 18 monthsn = 11,675
- ≥ 24 monthsn = 4,317
- Outcome
- Total body weight change across all AOMs
- Follow-up
- 18 and 24 months
Methodological detailsreal-world, telemedicine weight management clinic
- Real-world
- Telemedicine weight management clinic
Main finding
As reported in the abstract
Average total body weight reduction, all AOMs
≥ 18 months
−18.53%
average · CI −18.74%–-18.32%
≥ 24 months
−20.27%
average · CI −20.63%–-19.92%
Observational data: associations, not effects.
Further findings
Weight loss by AOM class
- Outcomes trended toward greater weight loss with long-acting AOMs vs oral AOMs
Original publication
Twenty‐Four Month Outcomes From a Real‐World Telehealth Obesity Treatment Clinic Using Obesity Medications. Obesity (Silver Spring). Published 1 March 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →